Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology. Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
View Top Employees from FoamixWebsite | http://www.foamix.com |
Employees | 32 (30 on RocketReach) |
Founded | 2003 |
Technologies | |
Industry | Topical, Pharmaceutical Manufacturing, Pharmaceuticals, Formulation, Drug Delivery, Dermatology, Gynecology, Foam, Skin, Psoriasis, Atopic Dermatitis, Acne, Rosacea, Wound, Burn |
Looking for a particular Foamix employee's phone or email?
David Schuz is the Senior Vice President of Foamix.
30 people are employed at Foamix.